HDM1005
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Ap
Huadong Medicine · Phase 3 · Not yet recruiting · Enrollment 200
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| HDM1005 | Obesity or overweight | n/r | 52 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 52 | n/r | n/r |